Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group
- 1 December 1990
- journal article
- Published by Elsevier in The Lancet
- Vol. 336 (8730-8731) , 1533-1535
- https://doi.org/10.1016/0140-6736(90)93308-c
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Adult T-cell lymphoma in israeli patients of iranian originCancer, 1990
- Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reactionBlood, 1989
- High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New OrleansScience, 1989
- Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic regionJAMA, 1986
- Lack of antibodies to adult T-cell leukaemia virus and to AIDS virus in Israeli FalashasNature, 1986
- ELISA HTLV RETROVIRUS ANTIBODY REACTIVITY ASSOCIATED WITH MALARIA AND IMMUNE COMPLEXES IN HEALTHY AFRICANSThe Lancet, 1985
- Human T-cell lymphotropic virus type-I antibodies in Falashas and other ethnic groups in IsraelNature, 1985
- Clinical Course of Retrovirus-Associated Adult T-Cell Lymphoma in the United StatesNew England Journal of Medicine, 1983
- HUMAN T-CELL LEUKAEMIA/LYMPHOMA VIRUS-ASSOCIATED LYMPHORETICULAR NEOPLASIA IN JAMAICAThe Lancet, 1983
- Antibodies to adult t‐cell leukemia‐virus‐associated antigen (atla) in sera from patients with atl and controls in japan: A nation‐wide sero‐epidemiologic studyInternational Journal of Cancer, 1982